Sanofi to Buy U.S. Biotech Firm for $2.5 Billion in Cancer Push

December 9, 2019

French pharma giant Sanofi agreed to buy U.S. biotech company Synthorx Inc. for $2.5 billion, almost triple its market value, accelerating a push into cancer under new Chief Executive Officer Paul Hudson.

Related Stories